AstraZeneca faces $198m bill for Seroquel litigation in US
Tuesday 10 August 2010
AstraZeneca tried to draw a line under the growing number of claims against its blockbuster anti-psychotic drug Seroquel yesterday when it paid out $198m (£124m) to claimants in the United States.
The agreement, which settles 17,500 claims against the Anglo-Swedish pharmaceuticals company, comes after patients complained they were not made aware of the risks associated with taking the drug – specifically that it could lead to diabetes. AstraZeneca has maintained that it has been open about the risks, adding yesterday that the only trial to consider the complaint found in its favour. The terms of the mediated deal are confidential.
Yesterday's agreement does not end the firm's litigation over Seroquel. As part of the deal, 2,900 claims have been dismissed, but as of 29 June Astra-Zeneca was defending 10,363 lawsuits involving 22,412 American plaintiffs.
The settlement also comes on top of the $520m (£327m) the company paid to the US Justice Department earlier this year to settle other cases relating to the marketing of Seroquel.
As part of its second-quarter results, published two weeks ago, AstraZeneca said it had reached an agreement with 4,000 claimants but because the amount of money was not material at the time, it was not obliged to release further details. In a statement yesterday, the company said the provision would be disregarded in calculating so-called core earnings and would therefore not affect the City's full-year earnings guidance.
"While the terms remain confidential and are subject to non-monetary agreements, we believe it was in the best interest of the company to explore resolving these cases through the mediation process," said a spokeswoman. "We remain committed to a strong defence effort, but will also continue to participate in good faith in court- ordered mediation."
The market welcomed the settlement, with AstraZeneca's shares gaining 1.54 per cent yesterday. Analysts described the announcement as "a modest but welcome development".
The settlement comes a month after rival GlaxoSmithKline said it was setting aside a record £1.57bn to settle claims relating to its diabetes drug Avandia. The deal effectively wiped out GSK's second-quarter earnings.
- 1 Notting Hill Carnival: Woman shares selfie after being ‘punched in face for telling man to stop groping her’
- 2 Joan Rivers: 'Palestinians deserve to be dead'
- 3 Daily Show's Jon Stewart destroys Fox News for its Ferguson coverage
- 4 Botched ice bucket challenge leaves man critically injured after plane drops hundreds of gallons of water
- 5 Friends reunion: Jennifer Anniston, Lisa Kudrow and Courteney Cox perform mini sketch on Jimmy Kimmel Live
Notting Hill Carnival: Woman shares selfie after being ‘punched in face for telling man to stop groping her’
YouTube video posted by Isis militants shows 'execution of 250 Syrian soldiers'
Joan Rivers: 'Palestinians deserve to be dead'
Daily Show's Jon Stewart destroys Fox News for its Ferguson coverage
Botched ice bucket challenge leaves man critically injured after plane drops hundreds of gallons of water
Exclusive: We share blame for creating 'jihad generation', says Muslim strategist
Robin Williams Emmys tribute led by Billy Crystal criticised for including 'racist' joke about Muslim woman
The Rotherham child abuse scandal is a tale of apologists, misogyny and double standards
Scottish independence TV debate: Pumped-up Alex Salmond bounces back in bruising second round against Alistair Darling
Do you realise just how foolish the UK looks?
Ukip Douglas Carswell defection: Tory MP jumps ship to join Nigel Farage
- < Previous
- Next >
iJobs Money & Business
Highly Competitive Salary: Austen Lloyd: CITY - An excellent new instruction w...
£500 per day: Harrington Starr: SQL Server Developer SQL, PHP, C#, Real Time,...
£600 per day: Harrington Starr: C#.NET Developer C#, Win Forms, WPF, WCF, MVVM...